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Abstract We have investigated the UDP-galactose-4P-epimer-
ase (GALE) enzymatic activity and mRNA expression in the rat
mammary gland during lactation. We report a dramatic increase
in the GALE enzymatic activity correlated with an increase in
the mRNA transcript expression. These results indicate a
transcriptional regulation of the enzyme during lactation in the
rat mammary gland. Our data are of double interest for further
investigation: first, the mammary gland provides a suitable
model for the characterisation of the transcriptional regulation
elements of GALE which are still unknown in mammals; second,
GALE expression could help to compensate UDP-galactose
deficiency in classic galactosaemia.
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1. Introduction
The mammary gland has been well studied because of its
particular function to induce the secretion of lactose to pro-
duce milk. The biochemistry [1] and endocrinology of lacto-
genesis are well-documented [2]. Lactogenesis becomes impor-
tant in the parturient mammary gland, where a complex of
hormones act on this quiescent tissue to initiate the secretion
of milk [3]. Lactose synthesis is a temporal, tissue- and sex-
speci¢c metabolic process. Lactose, which is a disaccharide
consisting of glucose and galactose, represents the major
free carbohydrate of milk [4,5] and is not found elsewhere
in the body.
The enzymes involved in the metabolism of lactose precur-
sors UDP-galactose and glucose [6] and in galactose metabo-
lism [7] have been very well documented. Although most of
these enzymes do not signi¢cantly vary their enzymatic activ-
ity around the period of lactation, a few studies have reported
an increase of the enzymatic UDP-galactose-4P-epimerase
(GALE) activity in the mammary gland of rabbits and rats
[8]. The rate of increase of the GALE activity, however, re-
mains uncertain since the data reported vary between a two-
fold [9] and a 300-fold increase [10] in rats during lactation.
GALE has a crucial role in galactose metabolism where it is
thought to maintain the UDP-galactose/UDP-glucose ratio
[11], essential for the incorporation of galactose in cells as a
source of energy. At present there is no accurate biological
model allowing the study of mammalian GALE expression.
We therefore proposed to investigate the rat mammary gland
as a tissue model for studying GALE expression. Our data
show a di¡erential expression of the GALE mRNA transcript
and enzymatic activity in the mammary gland at di¡erent
physiological stages.
2. Materials and methods
2.1. Animals
Two-month-old virgin female rats of the Wistar strain were used.
Rats were kept in a light- (lights on 07:00^19:00 h) and temperature-
(22^24‡C) controlled room, with free access to pelleted food and
water.
The virgin females were caged with fertile males on the night of
prooestrus. The presence of spermatozoa was checked in the vaginal
smear the following morning (designated day 0 of pregnancy). Rats
on days 7 and 19 of gestation were used. These stages correspond to
the beginning (BG) and the end of gestation (EG) respectively. The
day of parturition was considered to be day 0 of lactation. Litters of
lactating rats were adjusted to 10 pups post partum. Lactating rats
from days 7, 12 and 19 were used. These stages corresponding to the
beginning (BL), the middle (ML) and the end of lactation (EL) re-
spectively. After 21 days of lactation, pups were removed from the
rats which were taken 7 days after weaning (W).
Rats were killed by decapitation at di¡erent physiological stages:
virgin (V), during gestation (BG and EG), during lactation (BL, ML,
and EL) and after weaning (W). Cortex, muscle (quadriceps), abdomi-
nal and inguinal mammary glands were removed. Tissues used for
RNA extraction were homogenised with an ultra-Turax homogeniser
and frozen at 380‡C in acid guanidinium thiocyanate solution until
analysis. Tissues used for enzymatic activity assays were frozen at
380‡C immediately after removal.
2.2. GALE activity assay
Mammary glands and cortex from rats were solubilised by sonica-
tion in 300 Wl distilled water. Samples were centrifuged at 2000 rpm
for 2 min and supernatants were collected. For each stage at least
eight animals were killed. Endogenous GALE activity was measured
and calculated as described by Shin et al. [12,13].
2.3. Reverse transcriptase-polymerase chain reaction (RT-PCR)
analysis
GALE and L-actin mRNA levels were assessed using semiquanti-
tative RT-PCR assays. For each stage at least eight animals were
killed. The di¡erent tissues were treated independently for RNA ex-
traction and RT-PCR.
After homogenisation in acid guanidinium thiocyanate solution,
total RNAs were extracted using a phenol/chloroform solution and
quantitated by optical density at 260 nm wavelength. The quality of
isolated RNA was veri¢ed by agarose gel electrophoresis with ethidi-
um bromide staining.
For all assays, 1 Wg of each RNA sample was reverse transcribed in
a ¢nal volume of 20 Wl containing 1.25 WM of random hexamers, 10
mM of each deoxy (d)-ATP/dCTP/dGTP/dTTP (dNTP; Promega,
Madison, WI), 1.25 U/Wl of rRNasin Ribonuclease Inhibitor (Prom-
ega), reverse transcriptase bu¡er (250 mM Tris-HCl (pH 8.3), 250
mM KCl, 50 mM MgCl2, 2.5 mM spermidine and 50 mM DTT)
and 10 U/Wl of AMV reverse transcriptase (Promega). Additional
reactions were carried out omitting the reverse transcriptase to detect
ampli¢cation from contaminating genomic DNA. An additional tube
per assay did not contain RNA (blank) to detect contamination of
solutions and pipettors.
1 Wg of cDNA of each sample was used for PCR. Sense and anti-
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sense primers were designed to amplify across introns. This strategy
was used in order to detect by sizing any unspliced RNA and con-
taminating genomic DNA. Each PCR reaction was assessed in a ¢nal
volume of 50 Wl containing 0.05 mM of dNTP, 0.4 WM of primers,
Taq DNA polymerase bu¡er (500 mM KCl, 100 mM Tris-HCl (pH
9.0 at 25‡C), 15 mM MgCl2 and 1% Triton X-100) and 2.5 U of Taq
DNA polymerase. To quantify reaction products of PCR, 1 WCi of [K-
32P]dCTP (3000 Ci/mmol) was added to the reaction mix. Reactions
were overlaid with 100 Wl of light mineral oil and ampli¢ed for cycles
of 1 min at 94‡C, 1 min at 60‡C and 2 min at 72‡C followed by a ¢nal
extension of 5 min at 72‡C. For each assay, PCR fragments were
separated on 10% non-denaturing acrylamide gels for 90 min at 150
V. PCR products were detected by ethidium bromide staining and the
quantity of 32P incorporated in the PCR products was determined by
exposing the gel to a phosphorimager screen. The same procedure was
applied to measure mRNA variations isolated from rat skeletal
muscle and cortex of the same animals. The linear range for each
PCR ampli¢cation was determined by removing aliquots after 25,
28, 30, 35 and 40 PCR cycles. Linearity was also determined for
di¡erent amounts of cDNA templates.
Rat GALE primer sequence was designed on the basis of the rat
GALE sequence [14]. The following primers were used: 5P-CAA TTC
CAT TCG TGG AGA AG-3P and 5P-AGG CAG GTA CGG GTT
TCC CA-3P, with an expected product size of 320 bp. Rat L-actin
primer sequence was chosen from the rat L-actin gene sequence [15]
as: 5P-GGT CAC CCA CAC TGT GCC CAT CTA-3P and 5P-GAC
CGT CAG GCA GCT CAT AGC TCT-3P, with an expected product
size of 263 bp.
2.4. Statistical analysis
Variations in GALE activity and GALE mRNA level at the di¡er-
ent physiological stages tested were statistically analysed by a one-way
analysis of variance (ANOVA).
3. Results
3.1. GALE activity assay
GALE activity was quantitated using a radiometric assay
and was expressed in nmol/min/mg proteins. The activity val-
ues were calculated from the UDP-glucose standard curve
(Fig. 1A) where the UDP-glucose concentration was found
to be linear up to a concentration of 0.15 mM.
Enzymatic activity was measured at di¡erent stages during
lactation in the rat mammary gland and in the cortex. At least
eight assays were performed in triplicate. GALE activity was
found to vary during the lactation in the mammary gland
(Fig. 1B). In the virgin mammary gland GALE activity was
around 1 nmol/min/mg protein. This activity, however,
showed a more than ¢ve-fold increase during the middle of
lactation (ML) with a peak at nearly 5 nmol/min/mg protein.
This increase was shown to fall to less than 1 nmol/min/mg
protein at the end of lactation (EL), to reach a basal level of
activity. An analysis of variance showed signi¢cant increase of
GALE activity in the beginning (BL) (F(2,44) = 43.081;
P = 0.0049) and middle (ML) (P6 0.001) of lactation in com-
parison with the basal activity in the virgin (V) and weaning
(W) stages.
No signi¢cant variation was detected in the cortex during
the various stages of lactation (data not shown).
3.2. Expression of GALE mRNA
We examined the mRNA expression of GALE in rat mam-
mary glands, cortex and skeletal muscle by RT-PCR analysis
in virgin and weaning rats and during gestation and lactation.
In a preliminary study GALE transcripts were detected by
RT-PCR analysis performed on total RNA from di¡erent
tissue samples using speci¢c primers combined with the incor-
poration of 32P-labelled dCTP to quantitate relative amounts
of transcripts. In order to accurately determine relative
amounts of mRNA, we analysed the levels of mRNA produc-
tion of both L-actin and GALE during the time course of the
PCR. Ampli¢cation of L-actin and GALE mRNA from con-
trol mammary gland were positive functions of the number of
PCR cycles carried out, as shown in Fig. 2A. The slope of the
curve increased between 25 and 30 cycles and stabilised at 35
cycles. Thus, the number of 30 cycles was considered to be the
optimum for the determination of relative amounts of
mRNA.
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Fig. 1. A: UDP-glucose standard curve. Levels of radiolabeled
UDP-[14C]glucose in relation to the initial UDP-glucose concentra-
tion. Each point represents one assay. B: E¡ect of the lactation pe-
riod on the GALE mammary gland activity. GALE activity was
measured in virgin (V), lactating (beginning (BL), middle (ML) and
end (EL) of lactation) and in weaning (W) rats. GALE activity is
expressed in nmol/min/mg prot. Each bar chart represents the mean
of triplicates of at least eight values of activity þ S.E.M.
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Expression of GALE was normalised against L-actin in the
di¡erent tissues obtained by independently performed RNA
extraction (Fig. 2B). GALE mRNA expression was increased
about six times during lactation with a peak at the beginning
and the middle of lactation compared to a basal level in vir-
gin, gestating and weaning animals (Fig. 2c). The increase of
GALE mRNA expression during lactation was statistically
signi¢cant versus basic expression (F(6,49) = 3.167; P6 0.05)
(Fig. 2C). Skeletal muscle and cortex taken from the same
animals showed no signi¢cant variations in GALE mRNA
expression during these physiological stages (data not shown).
4. Discussion
The present report is the ¢rst comparative analysis of
GALE expression of both enzymatic activity and mRNA
transcript in the rat mammary gland during lactation. We
tested the GALE speci¢c activity at three di¡erent stages of
lactation in comparison to virgin and weaning stages when
there is no stimulation of the mammary gland. We report a
general increase of GALE activity in the rat mammary gland
with particularly a more than ¢ve-fold increase of speci¢c
activity in the middle of lactation. On weaning the activity
dropped rapidly to the unstimulated level. These results are
in accordance with the remarkable increase of GALE activity
during lactation shown by Shatton et al. [10] and thus con¢rm
a particular regulation of GALE in this tissue during the
di¡erent physiological stages tested.
As the increase in GALE activity of lactating mammary
glands was found to be due to a structural change of the
existing enzyme that leads to a more active form [16], we
attempted to determine whether it is a case of transcriptional
or post-translational regulation of GALE enzyme in the rat
mammary glands during lactation. We therefore tested
mRNA expression of GALE in rat mammary glands during
lactation. Interestingly, we found this variation not only in the
enzymatic activity but also in the mRNA transcript which
increased about six-fold during the beginning and the middle
of lactation and then dropped in the end.
These variations in GALE activity and mRNA are in ac-
cordance with the lactose level in mammary glands which
increases, at the end of gestation to reach a peak of concen-
tration on day 15 of lactation [17]. Moreover, GALE is spe-
ci¢cally expressed during lactose production in the mammary
gland since no increase of GALE mRNA expression was
found in muscle and cortex as expected.
Our results are the ¢rst evidence of a di¡erential expression
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Fig. 2. A: E¡ect of the number of PCR cycles on the mammary
gland L-actin and GALE ampli¢cation. Ampli¢cation is expressed
in log units. B: Representative phosphorimage of mammary gland
GALE and L-actin RT-PCR products. GALE and L-actin ampli¢ca-
tion products were tested in virgin (V), gestating (beginning (BG)
and end (EG) of gestation), lactating (beginning (BL), middle (ML)
and end (EL) of lactation) and weaning (W) rats. GALE, the upper
band, is 320 bp, and L-actin, the lower band, is 263 bp. C: E¡ect
of the gestation and lactation period on mRNA GALE expression
in the mammary gland. Relative amounts of GALE ampli¢cation
product are expressed as the ratio of GALE to L-actin. Each bar
chart represents the mean of at least eight experiments þ S.E.M., for
the physiological stages as follows: virgin (V), gestating (beginning
(BG) and end (EG) of gestation), lactating (beginning (BL), middle
(ML) and end (EL) of lactation) and weaning (W).
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of GALE mRNA during lactation in the rat mammary gland.
The signi¢cant increase of GALE activity indicates the capa-
bility of the mammary gland to respond to a functional re-
quirement by an increase of mRNA production. The physio-
logical variation supports the idea of a possible transcriptional
regulation of the enzyme during lactation. In this way our
work opens a new ¢eld for studying the regulation of
GALE expression in the mammary gland providing an accu-
rate model of expression. Indeed, although the human GALE
cDNA [18] has been sequenced no studies have been reported
concerning the molecular regulation of this enzyme in mam-
mals.
Furthermore, GALE plays a key role in galactose metabo-
lism. Mutations of the gene encoding this enzyme are respon-
sible for a minor form of galactosaemia [19]. Moreover, the
knowledge of the regulation of the gale gene may open the
way to develop a new strategy to induce the production of
UDP-galactose which has been shown to be de¢cient in pa-
tients with ‘classical’ galactosaemia [20]. The analysis of such
regulatory elements may be possible by using the di¡erential
expression of GALE in the mammary gland during lactation.
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